Evidence map›Paper›PMID 40621461›Full record

ArticleFrontiers in immunology2025

Exercise-related immune gene signature for hepatocellular carcinoma: machine learning and multi-omics analysis.

Cheng Pu, Lei Pu, Xiaoyan Zhang, Qian He, Jiacheng Zhou, Jianyue Li

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cheng PuSchool of Martial Arts, Shanghai University of Sport, Shanghai, China.
Lei PuThe Key Laboratory of Adolescent Health Assessment and Exercise Intervention of the Ministry of Education, East China Normal University, Shanghai, China.
Xiaoyan ZhangThe Key Laboratory of Adolescent Health Assessment and Exercise Intervention of the Ministry of Education, East China Normal University, Shanghai, China.
Qian HeDepartment of Preventive Medicine, Suzhou Wujiang District Second People's Hospital, Jiangsu, China.
Jiacheng ZhouDepartment of Interventional Medicine, Liyang Hospital of Chinese Medicine, Jiangsu, China.
Jianyue LiDepartment of Oncology, Jiangsu Provincial Hospital of Integrated Chinese and Western Medicine, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Exercise is known to regulate the immune system. However, its prognostic value in hepatocellular carcinoma (HCC) remains largely unknown. Objective: This study aims to construct a machine learning-based prognostic signature using exercise-related immune genes (EIGs) to predict prognosis in HCC. Methods: We obtained mRNA-seq and scRNA of HCC from GeneCards, GEO, TCGA and ICGC. EIG were obtained using WGCNA, differential gene expression analysis and CIBERSORT. Univariate COX analysis and 101 combinations of 10 machine learning algorithms were used to construct EIG prognostic signature (EIGPS), and survival analyses were performed. Furthermore, we conducted molecular subtyping, qRT-PCR, biological functions, immune infiltration, drug sensitivity, and single cell analyses on EIGPS. Results: Using WGCNA, differential gene expression analysis, and CIBERSORT, 59 EIGs were identified, of which 54 were associated with prognosis. EIGPS constructed by 7 EIGs (UPF3B, G6PD, ENO1, FARSB, CYP2C9, DLGAP5, SLC2A1) had the highest average C-index value (0.742), showing good predictive performance independent of clinical features. qRT-PCR results showed that CYP2C9 was lowly expressed in HCC cells, while all other genes were highly expressed. 7 EIGs were divided into two subtypes, with C2 exhibiting better anti-tumor immunity. Immunological biological differences between high- and low-risk groups based on EIGPS involved immune responses. EIGPS was mainly expressed in macrophages. The high-risk group had higher macrophage abundance and immune escape ability, as well as greater sensitivity to Afatinib and Alpelisib. Conclusions: We identified key EIGs and constructed an EIGPS that can effectively predict the prognosis of HCC, which offers avenues for better personalized treatments.

Indexed as

Biomarkers, TumorCarcinoma, HepatocellularLiver NeoplasmsMachine LearningTranscriptomeComputational BiologyFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMaleMultiomicsPrognosisTumor MicroenvironmentBiomarkers, Tumorexercise-related immune geneshepatocellular carcinomamachine learningmulti-omicsprognosis

Identifiers

PMID40621461
PMCPMC12226479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.